Llwytho...
Particular findings on lung CT in patients undergoing immunotherapy for bronchogenic carcinoma
BACKGROUND: Immune checkpoint inhibitors have become a valuable tool in the therapeutic strategy against metastasized non-small cell lung cancer (NSCLC) as they represent an effective and safe treatment option for many patients; however, the treatment response and side effects of this class of drugs...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | Wien Klin Wochenschr |
|---|---|
| Prif Awduron: | , , , , , , , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
Springer Vienna
2020
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7445205/ https://ncbi.nlm.nih.gov/pubmed/32430613 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00508-020-01667-0 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|